Dr Reddy’s aims for US Copaxone launch
Dr Reddy’s Laboratories is aiming to launch generic Copaxone (glatiramer acetate) in the US in the first half of its next financial year ending March 2020, chief operating officer Erez Israeli has revealed.
Dr Reddy’s Laboratories is aiming to launch generic Copaxone (glatiramer acetate) in the US in the first half of its next financial year ending March 2020, chief operating officer Erez Israeli has revealed.